Gazyva

Made by

• Chugai (Roche)

Active Ingredient

Obinutuzumab (genetical recombination)

Prospectus

Approval date

2018/7/2

Treats

• Follicular lymphoma

Dosages

• GAZYVA for Intravenous Infusion - 458799円／瓶